These findings imply that FK228 induction of FYN expression likely plays a protective role in synovial sarcoma biology, and that blocking FYN activity by PP2 can improve the efficacy of FK228 in synovial sarcoma treatment. This evidence concerns the gene FYN and synovial sarcoma.